Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yidu TechHKSE:02158 -1.51%72 Net Margin % is 18.93% as of Mar. 2026. GuruFocus rates HKSE:02158 with a GF Score™ of 72/100 and a GF Value™ of HK$6.13 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Yidu Tech ranks better than 74.74% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Yidu Tech's Net Income for the
six
months ended in Mar. 2026 was HK$99.2 Mil. Yidu Tech's Revenue for the
six
months ended in Mar. 2026 was HK$523.7 Mil. Therefore, Yidu Tech's net margin for the quarter that ended in Mar. 2026 was 18.93%.
The historical rank and industry rank for Yidu Tech's Net Margin % or its related term are showing as below:
HKSE:02158'
s Net Margin % Range Over the Past 10 Years
Min: -4304.91 Med: -78.04 Max: 9.09
Current: 9.09
HKSE:02158's Net Margin % is ranked better than 74.74% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 3
vs HKSE:02158: 9.09
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Yidu Tech Net Margin % Related Terms
Yidu Tech Net Margin % Historical Data
* Premium members only.
The historical data trend for Yidu Tech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02158 vs VEEV, BTSG, HQY: Net Margin % Comparison
For the Health Information Services subindustry, Yidu Tech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Yidu Tech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yidu Tech (HKSE:02158) has a Net Margin % of 18.93% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Yidu Tech and its competitors. According to the industry distribution chart, Yidu Tech ranks #168 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 25.3%.
Is Yidu Tech's Net Margin % too high?
Yidu Tech's current Net Margin % is 18.93%. The Healthcare Providers & Services industry median Net Margin % is 3.00. Yidu Tech's value of 18.93% is 531% above this industry median. Based on the distribution chart, Yidu Tech ranks #168 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Yidu Tech has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yidu Tech's Net Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Yidu Tech ranks #168 out of 665 companies for Net Margin %. This puts Yidu Tech in the upper half of its industry. The industry median Net Margin % is 3.00. Yidu Tech's value of 18.93% is 531% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 3.00, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yidu Tech's current Net Margin % of 18.93% is 531% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Yidu Tech and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yidu Tech's current Net Margin % is 18.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yidu Tech stock overvalued right now?
Based on GuruFocus' analysis, Yidu Tech (HKSE:02158) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$6.13, compared to a current price of HK$4.56 — trading 25.7% below its estimated fair value. The current Net Margin % is 18.93% and 531% above the Healthcare Providers & Services industry median of 3.00. Yidu Tech's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Yidu Tech (HKSE:02158), the current Net Margin % is 18.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yidu Tech (HKSE:02158) Overvalued in 2026?
Based on GuruFocus' analysis, Yidu Tech stock appears to be undervalued.
The current stock price of HK$4.56 is trading 25.7% below its estimated GF Value™ of HK$6.13.
GuruFocus considers Yidu Tech to be Modestly Undervalued.
Key valuation signals for HKSE:02158:
Net Margin %: 18.93%
GF Value™: HK$6.13 vs. price of HK$4.56 (25.7% below fair value)
Industry Position: 531% above the Healthcare Providers & Services median (#168 of 665)
No single metric tells the full story. See the HKSE:02158 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yidu Tech Inc offers healthcare solutions built on big data and artificial intelligence (AI) technologies. The company serves various healthcare industry participants, including hospitals, pharmaceutical, biotech, research institutions, insurance companies, etc. Its operating segments are: Big data platform and solutions, Life sciences solutions, and Health management platform and solutions. The majority of the company's revenue is generated from its Big data platform and solutions segment, which provides data intelligence platforms and data analytics-driven solutions (such as Eywa 5.0, Lingxi Intelligent Management, AI Middleware, etc.) for hospitals, healthcare institutions, regulators, and policymakers. Geographically, the company generates maximum revenue from Mainland China.
72GF Score
Get the complete analysis for HKSE:02158
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02158 has been successfully added to your 
